Home › Lupus › Illinois › Cicero
Lupus clinical trials in Cicero, IL
5 studies for Lupus are looking for participants at sites in and around Cicero (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RecruitingPhase 3
- Sl0044 50717, Willowbrook · 11 mi away
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
RecruitingPhase 3
- Willow Rheumatology Wellness, Willowbrook · 11 mi away
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
RecruitingPhase 3
- Research Site, Willowbrook · 11 mi away
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
RecruitingPhase 3
- Willow Rheumatology and Wellness PLLC, Willowbrook · 11 mi away
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
RecruitingObservational study
- Willow Rheumatology & Wellness, Willowbrook · 11 mi away
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Houston, TX13 studies
- Durham, NC12 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Tampa, FL9 studies
- Philadelphia, PA9 studies
- Clearwater, FL8 studies
- Santa Monica, CA8 studies
- Oklahoma City, OK8 studies
- Los Angeles, CA8 studies
- Boston, MA8 studies
Other studies in Cicero
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Prostate Cancer14 studies
- Cancer (all types)13 studies
- Acute Myeloid Leukemia11 studies
- Breast Cancer11 studies
- Colorectal Cancer10 studies
- Bladder Cancer8 studies
- Metastatic Cancer7 studies
- Melanoma7 studies
- Cardiovascular Disease7 studies
- Burkitt Lymphoma6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.